段迎喜主任医师运用疏肝健脾理论治疗胃痞病
Application of Shugan Jianpi Theory (Soothing Liver and Strengthening Spleen) in Treating Gastric Stuffiness by Chief Physician Duan Yingxi
摘要: 目的:分析段迎喜主任医师运用疏肝健脾理论治疗胃痞病患者的临床疗效。方法:选取我院于2022年1月~2022年12月收治的78例胃痞病患者为观察对象,为满足组间比对实验要求,按照随机抽样法将两组患者分为对照组、研究组,各39例。对照组患者给予常规西药治疗,研究组患者则在对照组的基础上联合使用段迎喜主任医师提出的疏肝健脾理论进行治疗,比对两组患者的治疗效果、应激指标、临床症状积分及不良反应发生情况。结果:在治疗周期结束后,相较于对照组,研究组患者整体治疗有效率更高(94.87% vs 79.49%, p = 0.042),不良反应发生率明显降低(2.56% vs 15.38%, p = 0.048);此外,研究组P物质(SP)水平升高,热休克蛋白(HSP)水平更低(p均<0.01),各临床症状积分亦显著低于对照组(p值范围:0.001~<0.01);研究组的。结论:胃痞病患者采取段迎喜主任医师的疏肝健脾理论进行治疗,可提升治疗有效率,改善应激指标,降低不良反应发生率,值得推广。
Abstract: Objective: To analyze the clinical effect of Chief Physician Duan Yingxi’s application of Shugan Jianpi theory (soothing liver and strengthening spleen) in treating patients with gastric stuffiness (TCM term, corresponding to functional dyspepsia, chronic gastritis, etc. in Western medicine). Methods: 78 patients with gastric stuffiness in our hospital from January 2022 to December 2022 were selected as the observation objects. To meet the requirements of inter-group comparison, the patients were randomly divided into a control group and a study group with 39 cases each. Patients in the control group were treated with routine Western medicine, while patients in the study group were treated with the Shugan Jianpi theory proposed by Chief Physician Duan Yingxi on the basis of the control group. The therapeutic effect, stress indexes, clinical symptom scores, and incidence of adverse reactions were compared between the two groups. Results: After the treatment cycle, the overall therapeutic effective rate of the study group was higher than that of the control group (94.87% vs 79.49%, p = 0.042); the level of substance P (SP) in the study group was higher than that in the control group, and the level of heat shock protein (HSP) was lower than that in the control group (both p < 0.01); the clinical symptom scores of the study group were lower than those of the control group (p value range: 0.001~<0.01); the incidence of adverse reactions in the study group was significantly lower than that in the control group (2.56% vs 15.38%, p = 0.048). Conclusion: The application of Shugan Jianpi theory by Chief Physician Duan Yingxi in the treatment of gastric stuffiness can improve the therapeutic effectiveness rate, optimize stress indexes, and reduce the incidence of adverse reactions, which is worthy of promotion.
文章引用:王舒, 段迎喜. 段迎喜主任医师运用疏肝健脾理论治疗胃痞病[J]. 临床医学进展, 2026, 16(2): 1425-1431. https://doi.org/10.12677/acm.2026.162529

参考文献

[1] 赵秦, 赵琦, 姬炫. 从中医病机“虚、瘀、郁”角度论治功能性消化不良伴焦虑抑郁状态[J]. 贵州中医药大学学报, 2023, 45(6): 15-19.
[2] 沈春霞, 王彦刚. 基于核心病机观浅析王彦刚论治慢性糜烂性胃炎经验拾萃[J]. 世界中西医结合杂志, 2023, 18(4): 676-680+713.
[3] 李家兴, 梁欣奕, 李慧臻. 李永成运用“开心气, 泻肝气”法治疗胃痞病肝郁气滞证经验[J]. 中国民间疗法, 2023, 31(5): 47-50.
[4] 梁绮婷, 周恒立, 李嘉丽, 等. 基于多中心住院病历数据的岭南胃痞病中医证治规律研究[J]. 中药新药与临床药理, 2022, 33(7): 994-1000.
[5] Taché, Y. and Bonaz, B. (2007) Corticotropin-Releasing Factor Receptors and Stress-Related Alterations of Gut Motor Function. Journal of Clinical Investigation, 117, 33-40. [Google Scholar] [CrossRef] [PubMed]
[6] Lan, J., Deng, Z., Wang, Q., Li, D., Fan, K., Chang, J., et al. (2024) Neuropeptide Substance P Attenuates Colitis by Suppressing Inflammation and Ferroptosis via the cGAS-STING Signaling Pathway. International Journal of Biological Sciences, 20, 2507-2531. [Google Scholar] [CrossRef] [PubMed]
[7] 刘伟锋, 吴东阳, 范丽丽, 等. 基于中医传承辅助平台探讨邓家刚教授治疗脾胃湿病的用药规律[J]. 世界科学技术-中医药现代化, 2022, 24(4): 1667-1675.
[8] 李婧. 栗德林教授治疗寒热错杂型胃痞病临床经验[J]. 中国中医药现代远程教育, 2021, 19(10): 86-87+95.
[9] 王阳, 王萍, 姜艾利, 等. 温艳东运用半夏泻心汤治疗胃痞病经验总结[J]. 中国中医基础医学杂志, 2020, 26(8): 1187-1189+1209.
[10] 孙肇阳, 马晓峰. 试论胃痞病的阶段传变与三级架构模型[J]. 天津中医药大学学报, 2020, 39(4): 413-416.
[11] 蔡和平, 侯丽, 董青, 等. 中医综合治疗晚期恶性肿瘤合并胃痞理论及应用探讨[J]. 陕西中医, 2020, 41(6): 783-785.
[12] 蔡和平, 祁烁, 董青, 等. 基于“温阳补虚, 理气消胀”理论综合治疗晚期恶性肿瘤合并胃痞病疗效观察[J]. 现代中西医结合杂志, 2020, 29(15): 1612-1615.